To improve outcomes we must define and measure them: Toward defining remission in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 63, Issue 3, 2011, Pages 587-589

  O'Dell, James R ^a   Mikuls, Ted R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE ACTIVITY; HUMAN; LONG TERM CARE; PATIENT CARE; PRIORITY JOURNAL; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; HUMANS;

EID: 79953754194     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30199     Document Type: Review

References (7)

1. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
2. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism preliminary definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63: 573-86.
3. Grigor C, Capell HA, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9. (Pubitemid 38942816)
4. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90. (Pubitemid 41612204)
5. Moreland LW, O'Dell JR, Paulus H, Curtis JR, Bridges SL Jr, Zhang X, et al. TEAR: Treatment of Early Aggressive RA: a randomized, double-blind, 2-year trial comparing immediate triple DMARD versus MTX plus etanercept to step-up from initial MTX monotherapy [abstract]. Arthritis Rheum 2009;60 Suppl: S707.
6. O'Dell JR, Mikuls TR, Colbert RA, Weinblatt ME. Rheumatoid Arthritis Consensus Conference, July 22-3, 2010: clinical trial priorities and trial design issues. Arthritis Rheum. In press.
7. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69: 964-75.